Clinical Trials
9 trialsNCT04390945 2022-02-03
Camrelizumab Combined With CRT for Treatment of Patients With Local Recurrence of Esophageal Cancer
The First Affiliated Hospital of Henan University of Science and Technology
Phase 2 Unknown
NCT00183898 2019-05-16
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
University of Southern California
Phase 2 Unknown
NCT02177552 2019-02-15
SEED
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02741856 2018-10-25
SCOPE2
Velindre NHS Trust
Phase 2/3 Unknown
NCT01843829 2014-03-24
NeoSCOPE
Velindre NHS Trust
Phase 2 Unknown
NCT00509561 2012-12-18
Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer
Wales Cancer Trials Unit
Phase 2/3 Unknown
NCT00821912 2012-02-28
TaxXel
Karolinska University Hospital
Phase 1/2 Unknown
NCT00865982 2011-08-05
DCXAIOCHARITE
Charite University, Berlin, Germany
Phase 2 Unknown
NCT00453323 2010-07-12
Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer
National Cancer Center, Korea
Phase 2 Unknown